In view of fundamental criteria, the company is among low performers as far as mid or long-term investment strategy is concerned.
The company has poor fundamentals for a short-term investment strategy.
Strengths
No significant strength
Weaknesses
According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company has insufficient levels of profitability.
One of the major weak points of the company is its financial situation.
Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Analysts covering the stock have recently lowered their earnings forecast.
For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Most analysts recommend that the stock should be sold or reduced.
The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
